pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-516b-1 |
Genomic Coordinates | chr19: 53736845 - 53736934 |
Synonyms | MIRN516-4, MIRN516B-1, MIRN516B1, MIR516B1 |
Description | Homo sapiens miR-516b-1 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
pre-miRNA | hsa-mir-516b-2 |
Genomic Coordinates | chr19: 53725442 - 53725526 |
Synonyms | MIRN516-3, MIRN516B-2, MIRN516B2, MIR516B2 |
Description | Homo sapiens miR-516b-2 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | |||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-516b-3p | ||||||||||||||||||||||||||||||||||||||||||
Sequence | 56| UGCUUCCUUUCAGAGGGU |73 | ||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||||||||||||||
Experiments | Array-cloned | ||||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SIKE1 | ||||||||||||||||||||
Synonyms | SIKE | ||||||||||||||||||||
Description | suppressor of IKBKE 1 | ||||||||||||||||||||
Transcript | NM_001102396 | ||||||||||||||||||||
Other Transcripts | NM_025073 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SIKE1 | |||||||||||||||||||||
3'UTR of SIKE1 (miRNA target sites are highlighted) |
>SIKE1|NM_001102396|3'UTR 1 CTGAACTCTGAATGATGGCTGGAGATTGTCTATCAAGGAAGGAAGTTACTGTCTTCCCATTCAAGTACTGTCCATTAAGT 81 GTCTTGCCTCAGATTTGATTTAATCTTAATTAAAGGTATCAGGTGGCAATTTAGAATTCCAGTCAATATTGGCTGTCCAC 161 AGTTCTCAGATGTGTTAATGTGAATACTACATGCTGAATTTCACCATTCCTTTCTCAAAGAGACTACTTTTAATTTTCAT 241 TTCTGGGACCTTGATTTATATAAACTATGTTTTCAGTTCTTTGTTATTTTTCACATCTCTGAAACTTTGAGCATTTTTTA 321 TAAGCCAGCAATTTATTTTACATAGCATTGTAAAATACACTTCTAGGAAATTTTAGGAAAGATTTAACTGTTTAAATCTA 401 TTTGGCATAAACCTTGATTTTTTTTTTCCATTTGACAAAAATAATACAATTCCACAGAACTAGATCAGCAGATTCTCTGA 481 TTTGTAATGTCATTCACCTGTGACATTTTAAGTCTCTCTGGTGCTAAGAATTGGCACTTTATAGCCTGGTGCCTTTACTT 561 TTAATTTGAGAGAACCTACTGCTAGTCCCAGGAAACACACTTGGAAATAAGTCAGCTATTTTTTTTGCCCAGTGATGCTA 641 TAGTTGTCATATTGTCCAAAGTTCATATTGTTCAAAGCTGAGGAGCTTGTCCTGTGTATGTGAATGCACACATGTGCACT 721 TAGTTCAAATACTAAAAGTAGCTTTTATTAAATATAATCAGCCAAAAACACACACAAAATAAAAAAAACAAATATAAGTA 801 GTCAGTTTTTCAATGTTATCCTACTAGTTCTACATTCTATTTTAATTTTTATACAATTTCCATTTTATAGTTAAGAACCA 881 TCACTTACTTGGATTGGATGTCTTTCATTCCTAGCACTAATAGTTGGCTTTCTTTTTTTTTGTTTACATAGAAGCAGGGT 961 TTTTTTTTATCTTTTTTCTTTTTTTTTGTTTAAGCTATATAAAAAGGTGAGGAAGCAGTTTTGTTACCTAATGAAAATTA 1041 TTACACTCATAATGCTGTGTAGGCAACATTGAGATTCAAATGCCCAGTGGTCAACTGGGTTCACTCATCAACTCATTCCC 1121 GTCCCAGTTTACTCACATTTCAAATTTATAAATTTCTTCATGTTATACTATTCTATTTAGATTTGCCCAGAATTAGTTGA 1201 AATAATGCTAAACCTGTCAATATTTTCCAGTAACATTAAGCACCATACTGCATGGGAGAGACACAGTACTAAAAAGAGTT 1281 GTTAGTGCTTTATGTGAGTGATATTTCTTTCGTAATGCTATAAAGAACTACAGTTAAAATAACAAAATATTTTAAAGATG 1361 TCCTAAAAGCATCTGATCCCAGTAATAACTAATGGATGTCATCTAGAGCAGTGGGTGTTAATGAATAGGTATATGTCATT 1441 TAAGAATTTTTCAAATTTCTGTTTGATATCCTGCATAGAATTTGACAAAAAAAACACTTCCAAGTGTGAGCATTTTTTAT 1521 TTCATTTCCCAAGAGTAAGTAAGTAACTATTAGCCCAGCCATCTGCCTCGAAGTATACCTTAAGTGACCCCATAAATCCA 1601 TTCAAGAGGCAGGTACTCTATACCATTTGGCAGCCACGGCCAAACCTACCATGGCCAGATTTCAGTGAAAATGATGAAGT 1681 AATCAAATCAAGGTATAATATGGTGTCCCTTTATGTGCTTTATGTTCCTTTAGAGCTGTTTATAAAGTTCTTTATATCTC 1761 AAGTGTTAGGATAAATCGACATACTAACTTTTCCCCCTGCAAAATTAAAAGCCTGAGGTACAAGTCTAAGAAGCTTTTAG 1841 TGCTCTACATAATATAAATTCTGGCTGGTGTTAATGCTATGAAGATAATATGTAGTTAGAAAATTGAGTCGGGGAGGAAT 1921 GCTCTTCATTTTAAGTGGATTTTAAAGTTTCTCCTTGAGTGGATGAAGAACTTGCCTGGTTTGCAAAAATCTTAGTTCAA 2001 AATTATATTTTCTAACAAAAACTGCATTTTGAGAAGATAAGCTAATTTTACTCAGTAGTAAGTCAAATGAGGAAGTGCAG 2081 AGGGTTTTTTTACATATATATAGCAACCTTGTCAAGTGGTCCTCACAAGAGTCATAAATACTTTGTAATTAGCACAGTAT 2161 ATTCAGCAGTGTATAACTCTACAAATAGTACCTTATATTAGTGTAGTATTATATCAATATCTTATGTATAATTCTTATAT 2241 TAATACCTTATGCATAATTGGATTCAAACATTGAAGGTCTATTTTAGTGTTCTTCAAAATGTGCTTCCCTGACCTACTGA 2321 AATAGAAACTTGGTGATGAAGTTCAAGAATTTGTATTCTAATCATCTCAAACAATTCCTAAAGACACTGATTTTAAAATA 2401 TCTAGTCTAGGCCCCATTGTGTAATAGTTAGCACTCTAAAAGATGAAAAAGAAAATAGTCTATGTGCCAACCACTTCATT 2481 AGTACTTATGAATTTAAAAATGAAAAAGTCTGGTACAGGAGACAAGTATATATATAAAATTATAATGCAGTGTGATAAAT 2561 CCATTATAGTATGTATAAGATACAGAAGAGGGACTTTAAACTTGAGAATTCAATAGAGATAATAAATGGGTAGGAGGGAA 2641 ATAGAAAACTTTGGTGCCACAAAAGCAAAGTATGTATGGTATTGCCAATAATAGCTACCATCTATTGAGTGCTTTACTAC 2721 CTGTCAGGTACTGTATTATATAAACTCCATTTTAACTGTACCTCATTTTGCAGATACTCAGGCACAAGGAGGTGGTTATT 2801 TGTCCAAACTGGAACCAAGATTCAAACCCAGACAGAGTCTTAAGCACATTTTTAATCACTAACTAACTTGAGATGCCTAA 2881 ATGCCAAATACTGTTGGGAGTTCAAGTGGTTCTTGATTAGCAAAATCTATTTTTATTAGTGCAAAAGAAACACCACAGCT 2961 TATAAAGTATTATGAATTCAATAAATGGAGTCTTAACTAATGAGATATTATTTTCTAGAATGGTGTAGCTGAGAGTATGT 3041 GTGATTCAACTGAAAGGAATAATGTTTAATCAGTGACTCTTACTATATACAGGAAAAGGTGCAGTTCTGTCTTTCAAATC 3121 TGCCTCCTTACCATATTGGCTTACATCCCTCATGCTGTTTTCTTGTGTTTGCTAGAAAGTTGTTGCCAAGCCAAATGTCA 3201 TGGCCATGTTGAAGGCAAGGAAGAAAAAATGGAAATGGCCTGTGCCAGCTATATATATCGCCTTTTATGAGGGAAAGCAA 3281 AGCTTTCTCAGAAATCCCAAATGGATTTTCCCTTGACTTAATTGCCTGACCAGTTAAATGGCCACTGGTACCTGCAAAGA 3361 AAGCAGGGTACATAGCTGTCCCAAATAAAATCAGTATTAGCAAGAAGAAAGAATATTGAGAAAGCAATTAACAGTGTCTG 3441 TGACTGTGACATGTCTGTGACTTTATATTGTCAAGTCCTTTCCCCTTGAATATAGTTTTGGAAGAATTAGCTGAAGGAGT 3521 GTGTTGACATTGAATGGCCAAGAGAATGGGCTGTAGCAGACATCTGTCATTTCTCTTTTGGCTGCCCAGTATCCTAACTC 3601 CTGTGTTTAAGGAATCCCTCACCTAATGAGGCAGAGCATTTCTTCCTCCTAAAGAATTTGAAAGTACCAGGTAATGTTTT 3681 CTCAGCCTCCTTTTGCAGCTAAGGAAGAAACATCTGCCTTCAATTTTAAAATTAGTGATACAAAGAAGGAGGGAACCATG 3761 CAGATTCCTTTGAAGATGGTGATTAACAACACTACTGCATTCATCTCCACAGAGGTACAGCAAAAGTGATTTAGTTAGCG 3841 ATAACCTCTAATTCTATTTTTTTATTTTTATTTTTTGAGACAGTCTTGCTCTGTCAACCAGGCTGGAGTGCAGTAGCACT 3921 GTCTTAACTCACTGCAACCTCCACCTCCTGGGTTCAAGCGATTCTCCTGCCTCAGCCTCCCAAGTCGCTGGGATTACAAG 4001 TGCCCACCACCATGCACAGCTAATTTTTGTGTTTTTAGTAGATGGGGTTTCTCCATGTTGGCCAGGCTGGTCTCGAACTT 4081 ATGACTTCAGGTGATCCGCCCGCCTTGGCCTCCCAAAGTGCTGGGATTATAGGCGTGAGCCACTGTGCCTGGCCTGTAAC 4161 CTCTAATTCTTGTTTGCTGGCTGTCCTAGAGATCCTGAGAATTACTTTTAATAAAATCATTTTTTTGCTGTTATTAAAAC 4241 TAACCTGAATTGCCTAAAACCAAGAACTCTGCTTGATAAAATAAGCATAGTTTTAGGAACAGCCATGCAGATATAAATTT 4321 TATCAACACTTTATACATAATTTGGGACTTATATTTAAATGTAATATTTGATGCTTATAAAAGGGTAAATGGGGAATGCA 4401 AATAAATTATCAAGCATAATAACTCATCACCTAACTTAAGAATAACATTATGAGTGCTTGTATTTTATCTATTTGAGCTC 4481 TTCTCCTATCTTTGCCGACCCCCCCGCTCTCTTTTTAATAGATTTGTTCGAATGTAGAAAGACCTAAAATACATATGTAT 4561 CCCTAAAGTGACTTATTTTATAGTTTTCTTTCTTTTTGAACTTCAAAAAAATTGTATCATACTCTATGTAGTCTAAGGAT 4641 TTGGTTTTTTTCACTCAACATGTCTCTAGAATTCACAAGTTTTATTGTTTTATAGCTGTCATTTTCATTGATGTATATTT 4721 CATTGTTGGGTTATACAACATATTGTTAAGGAATACATACATATATAATAAATTATACATTTTTTAAAAAAAAAAAAAAA 4801 AAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293S | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084064. RNA binding protein: AGO2. Condition:CLIP_noemetine_AbnovaAb
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
CLIP-seq Support 1 for dataset GSM1084064 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_noemetine_AbnovaAb |
Location of target site | ENST00000369528.5 | 3UTR | AAAAAGGUGAGGAAGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
85 hsa-miR-516b-3p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT077049 | SMARCE1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT155261 | IFNAR2 | interferon alpha and beta receptor subunit 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT446119 | ASTN1 | astrotactin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447355 | STOM | stomatin | ![]() |
![]() |
2 | 2 | ||||||
MIRT469329 | RGP1 | RGP1 homolog, RAB6A GEF complex partner 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT470201 | PSAT1 | phosphoserine aminotransferase 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT475944 | GXYLT1 | glucoside xylosyltransferase 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT498268 | KIAA1644 | KIAA1644 | ![]() |
![]() |
2 | 2 | ||||||
MIRT501725 | OVOL1 | ovo like transcriptional repressor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT522860 | KIAA1551 | KIAA1551 | ![]() |
![]() |
2 | 2 | ||||||
MIRT527900 | B3GALT5 | beta-1,3-galactosyltransferase 5 | ![]() |
![]() |
2 | 4 | ||||||
MIRT528557 | DNAAF3 | dynein axonemal assembly factor 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT531250 | peptide deformylase, mitochondrial | ![]() |
![]() |
2 | 2 | |||||||
MIRT534410 | SENP1 | SUMO1/sentrin specific peptidase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT544656 | MED19 | mediator complex subunit 19 | ![]() |
![]() |
2 | 2 | ||||||
MIRT550681 | YARS | tyrosyl-tRNA synthetase | ![]() |
![]() |
2 | 2 | ||||||
MIRT557208 | HNRNPF | heterogeneous nuclear ribonucleoprotein F | ![]() |
![]() |
2 | 4 | ||||||
MIRT611532 | DDB1 | damage specific DNA binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT612087 | TIMM10 | translocase of inner mitochondrial membrane 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT616535 | PARD6B | par-6 family cell polarity regulator beta | ![]() |
![]() |
2 | 4 | ||||||
MIRT616738 | DCTN5 | dynactin subunit 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT616754 | SVOP | SV2 related protein | ![]() |
![]() |
2 | 4 | ||||||
MIRT617380 | FAM227A | family with sequence similarity 227 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT617624 | RAB3IP | RAB3A interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT620778 | MT1A | metallothionein 1A | ![]() |
![]() |
2 | 2 | ||||||
MIRT623172 | NAA50 | N(alpha)-acetyltransferase 50, NatE catalytic subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT626034 | AREL1 | apoptosis resistant E3 ubiquitin protein ligase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT627376 | PRICKLE4 | prickle planar cell polarity protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT630533 | AGO3 | argonaute 3, RISC catalytic component | ![]() |
![]() |
2 | 2 | ||||||
MIRT631686 | NQO2 | N-ribosyldihydronicotinamide:quinone reductase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT633896 | FGF10 | fibroblast growth factor 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT635933 | PLA2G12A | phospholipase A2 group XIIA | ![]() |
![]() |
2 | 2 | ||||||
MIRT636275 | RFFL | ring finger and FYVE like domain containing E3 ubiquitin protein ligase | ![]() |
![]() |
2 | 2 | ||||||
MIRT636285 | RAD51L3-RFFL | RAD51L3-RFFL readthrough | ![]() |
![]() |
2 | 2 | ||||||
MIRT636502 | GDAP1L1 | ganglioside induced differentiation associated protein 1 like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT638037 | SHPK | sedoheptulokinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT639162 | LAMTOR3 | late endosomal/lysosomal adaptor, MAPK and MTOR activator 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT639571 | GORASP1 | golgi reassembly stacking protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT641248 | CENPN | centromere protein N | ![]() |
![]() |
2 | 2 | ||||||
MIRT643650 | MYOCD | myocardin | ![]() |
![]() |
2 | 2 | ||||||
MIRT645490 | TRIM63 | tripartite motif containing 63 | ![]() |
![]() |
2 | 2 | ||||||
MIRT648016 | SLCO4C1 | solute carrier organic anion transporter family member 4C1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT648102 | LRRFIP1 | LRR binding FLII interacting protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT648729 | HIST1H2BD | histone cluster 1 H2B family member d | ![]() |
![]() |
2 | 2 | ||||||
MIRT650177 | LILRA2 | leukocyte immunoglobulin like receptor A2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT652787 | TCEANC2 | transcription elongation factor A N-terminal and central domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT653248 | SORD | sorbitol dehydrogenase | ![]() |
![]() |
2 | 2 | ||||||
MIRT654859 | PPM1F | protein phosphatase, Mg2+/Mn2+ dependent 1F | ![]() |
![]() |
2 | 2 | ||||||
MIRT655533 | PAG1 | phosphoprotein membrane anchor with glycosphingolipid microdomains 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT656390 | MCU | mitochondrial calcium uniporter | ![]() |
![]() |
2 | 2 | ||||||
MIRT656881 | KIF1C | kinesin family member 1C | ![]() |
![]() |
2 | 2 | ||||||
MIRT657083 | JMY | junction mediating and regulatory protein, p53 cofactor | ![]() |
![]() |
2 | 2 | ||||||
MIRT657629 | GPX8 | glutathione peroxidase 8 (putative) | ![]() |
![]() |
2 | 2 | ||||||
MIRT658295 | FAM83F | family with sequence similarity 83 member F | ![]() |
![]() |
2 | 2 | ||||||
MIRT659432 | COL1A1 | collagen type I alpha 1 chain | ![]() |
![]() |
2 | 2 | ||||||
MIRT659791 | CBLB | Cbl proto-oncogene B | ![]() |
![]() |
2 | 2 | ||||||
MIRT660153 | BRCC3 | BRCA1/BRCA2-containing complex subunit 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT660490 | ARRDC3 | arrestin domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT660503 | ARPC2 | actin related protein 2/3 complex subunit 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT666356 | SIKE1 | suppressor of IKBKE 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT677774 | FKTN | fukutin | ![]() |
![]() |
2 | 2 | ||||||
MIRT688556 | DCAF16 | DDB1 and CUL4 associated factor 16 | ![]() |
![]() |
2 | 2 | ||||||
MIRT697415 | ZFP91 | ZFP91 zinc finger protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT709468 | KRTAP19-1 | keratin associated protein 19-1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT711154 | WDR82P1 | WD repeat domain 82 pseudogene 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT711467 | SRD5A1 | steroid 5 alpha-reductase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT712515 | ENPP5 | ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative) | ![]() |
![]() |
2 | 2 | ||||||
MIRT712661 | PCTP | phosphatidylcholine transfer protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT713304 | TYRP1 | tyrosinase related protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT714597 | HSPA4L | heat shock protein family A (Hsp70) member 4 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT716603 | MPPED1 | metallophosphoesterase domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT717537 | PYGO2 | pygopus family PHD finger 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718058 | CYP3A5 | cytochrome P450 family 3 subfamily A member 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718539 | PIGQ | phosphatidylinositol glycan anchor biosynthesis class Q | ![]() |
![]() |
2 | 2 | ||||||
MIRT719768 | ZNF236 | zinc finger protein 236 | ![]() |
![]() |
2 | 2 | ||||||
MIRT720162 | PNPO | pyridoxamine 5'-phosphate oxidase | ![]() |
![]() |
2 | 2 | ||||||
MIRT720360 | ZBTB8B | zinc finger and BTB domain containing 8B | ![]() |
![]() |
2 | 2 | ||||||
MIRT721182 | HOPX | HOP homeobox | ![]() |
![]() |
2 | 2 | ||||||
MIRT721278 | RAD54L2 | RAD54 like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT721357 | ENTHD1 | ENTH domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT721504 | CARHSP1 | calcium regulated heat stable protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT721918 | LINGO2 | leucine rich repeat and Ig domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT722278 | LURAP1 | leucine rich adaptor protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT722789 | FUT4 | fucosyltransferase 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT724390 | ABAT | 4-aminobutyrate aminotransferase | ![]() |
![]() |
2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|